In a bid to beef up its health care business, Tokyo-based leading chemical manufacturer Asahi Kasei has agreed to take over Resuscitation devices maker ZOLL Medical (NASDAQ:ZOLL) in a deal worth roughly $2.21 billion. The transaction, which has been cleared by the Boards of both companies, is expected to consummate in second-quarter 2012.
ZOLL Medical is a leading player in the global market for external defibrillators (worth more than $1 billion) and competes with Physio-Control, a wholly owned … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards